Skip to main content

The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism.

Stokes FJ, Ivanov P, Bailey LM, Fraser WD

Publication: Clin Chem (2011) • Vol 57 • Page 138-40PMID: 20974796View on PubMed

Purpose

The purpose of this paper was to determine the effects of anticoagulant type, delayed centrifugation, and storage of plasma and serum on the measurement of C-terminal telopeptide of type 1 collagen (Beta-CTX), N-terminal propeptide of procollagen type 1 (P1NP), osteocalcin (OC), bone-specific alkaline phosphatase (bone ALP), and parathyroid hormone (PTH) in specimens from patients with metabolic bone disease.

Conclusion

Baseline values of the analytes were highly correlated and not statistically different between lithium heparin plasma, EDTA plasma, or serum. P1NP and bone ALP were stable in serum and plasma, regardless of anticoagulant, a 48 h room temperature centrifugation delay of whole blood, or storage of serum or plasma for 7 days at room temperature or 28 days at 2-8 degrees C (the longest durations tested). PTH concentrations were stable in lithium heparin and EDTA plasma during all storage conditions, however levels decreased in serum when centrifugation of whole blood was delayed by 24 h (room temperature), when serum was held at room temperature for 48 h, or when serum was held at 2-8 degrees C for 14 days. OC and Beta-CTX showed varying stability based on storage temperature, duration, anticoagulant type and use of plasma versus serum, but they were each generally more stable in EDTA plasma than lithium heparin plasma or serum.

Studies (1)

Purpose

The purpose of this study was to determine the effects of anticoagulant type, delayed centrifugation, and storage of plasma and serum at room temperature or 2-8 degrees C on the measurement of Beta-CTX, P1NP, OC, bone ALP, and PTH in specimens from patients with metabolic bone disease. All serum and plasma specimens were frozen at -70 degrees C until analysis.

Summary of Findings

Baseline values of the analytes were highly correlated and not statistically different between lithium heparin plasma, EDTA plasma, or serum. P1NP and bone ALP were stable in serum and plasma, regardless of anticoagulant, after 48 h room temperature delays in centrifugation of whole blood, storage of serum or plasma for 7 days at room temperature, or storage for 28 days at 2-8 degrees C (the longest durations tested). PTH concentrations were stable in lithium heparin and EDTA plasma during all storage conditions, however levels decreased in serum when whole blood was held at room temperature for 24 h prior to centrifugation, when serum was held at room temperature for 48 h, or when serum was held at 2-8 degrees C for 14 days. OC and Beta-CTX showed varying stability based on storage temperature, duration, anticoagulant type and use of plasma versus serum, but they were each generally more stable in EDTA plasma than lithium heparin plasma or serum.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Other diagnoses
  • Platforms

    PeptideClinical chemistry/auto analyzer
    ProteinClinical chemistry/auto analyzer
    ProteinImmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Metabolic bone disease
    Biospecimen AcquisitionAnticoagulant
    EDTA
    Lithium heparin
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    14 d
    2 h
    24 h
    28 d
    4 h
    48 h
    7 d
    8 h
    StorageStorage temperature
    2-8 degrees C
    Room temperature
    StorageTime at room temperature
    1 h
    2 h
    24 h
    4 h
    48 h
    8 h